{{Rsnum
|rsid=13430864
|Gene=AOX2P
|Chromosome=2
|position=200783916
|Orientation=plus
|GMAF=0.06015
|Gene_s=AOX2P
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(G;G)
|geno2=(G;T)
|geno3=(T;T)
}}{{ population diversity
| geno1=(G;G)
| geno2=(G;T)
| geno3=(T;T)
| CEU | 0.0 | 0.0 | 100.0
| HCB | 0.0 | 0.0 | 100.0
| JPT | 0.0 | 0.0 | 100.0
| YRI | 8.2 | 35.4 | 56.5
| ASW | 1.8 | 50.9 | 47.4
| CHB | 0.0 | 0.0 | 100.0
| CHD | 0.0 | 0.0 | 0.0
| GIH | 0.0 | 1.0 | 99.0
| LWK | 5.5 | 40.0 | 54.5
| MEX | 0.0 | 0.0 | 0.0
| MKK | 2.6 | 30.1 | 67.3
| TSI | 0.0 | 0.0 | 0.0
| HapMapRevision=28
}}{{PMID Auto GWAS
  |PMID=22760553
  |Trait=Response to citalopram treatment
  |Title=Genome-wide pharmacogenomic study of citalopram-induced side effects in STAR*D.
  |RiskAllele=G
  |Pval=5E-7
  |OR=NR
  |ORtxt=NR
  |OA=1
}}

{{on chip | Affy GenomeWide 6}}